Reply To: Traders Market Weekly: Central Banks and Big Tech Calibrations

#62449
Truman
Participant

Johnson & Johnson files litigation against the U.S. Dept. of HHS as well as the Centers for Medicare and Medicaid Services to challenge the innovation-damaging drug pricing provisions of the Inflation Reduction Act (IRA)

(JNJ 157.16, -1.90, -1.2%):